Interestingly, NFATC4 knockdown can reverse the chemoresistance of CAMTA1-silenced colorectal cancer cells to oxaliplatin, and this cellular event is partly mediated by an interacting protein, PPP3CA, which together with CAMTA1, competitively binds to NFATc4. The gene discussed is CAMTA1; the disease is colorectal cancer.